The National Drug Scheduling Advisory Committee (NDSAC) made the following decision on the scheduling of naproxen sodium products.
| Naproxen sodium 220 mg | Schedule |
|---|---|
|
Recommended maximum daily dose of more than two tablets per day (i.e., more than 440 mg) |
Schedule 1 |
|
Recommended maximum daily dose of two tablets (i.e., 440 mg) |
Non-prescription More than 30 tablets per package – Schedule 2 (i.e., must be behind the pharmacy counter) 30 tablets or fewer per package – Schedule 3 (i.e., may be sold in the patient services area of the pharmacy) |
Originally published in the July 14, 2009, issue of The Link
